BioNxt Solutions Inc. (CSE:BNXT)

Canada · Delayed Price · Currency is CAD

0.5500

-0.0200 (-3.51%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	26.99K	372.25K	297.44K	286.50K	345.65K
Pharmaceuticals Growth	-92.75%	25.15%	3.82%	-17.11%	66.08%
Total	26.99K	372.25K	297.44K	286.50K	345.65K
Total Growth	-92.75%	25.15%	3.82%	-17.11%	66.08%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Austria	6.22K	81.70K	267.36K	112.36K	-
Austria Growth	-92.38%	-69.44%	137.95%	-	-
Germany	16.35K	19.52K	21.15K	129.02K	345.65K
Germany Growth	-16.23%	-7.70%	-83.61%	-62.67%	66.08%
Switzerland	4.41K	3.53K	3.47K	3.41K	-
Switzerland Growth	24.86%	1.93%	1.61%	-	-
Korea	-	267.50K	-	-	-
Israel	-	-	5.47K	-	-
USA	-	-	-	41.71K	-
Total	26.99K	372.25K	297.44K	286.50K	345.65K
Total Growth	-92.75%	25.15%	3.82%	-17.11%	66.08%

Source: S&P Global Market Intelligence.